BioSpace News Archive

Microbot Medical Inc. (Nasdaq: MBOT), announced that Japan is the most recent global jurisdiction to recognize the unique interface design of the LIBERTY® Robotic System’s remote controller.

Zhongchao Inc. announced the renewal of the partnership between Zhongchao Medical Technology Co., Ltd., of which Zhongchao consolidates the operations and financial results through a series of contractual arrangements and Johnson & Johnson Investment Limited.

Transcend Therapeutics today announced that it closed its Series A funding round of $40 million.

Avidity Biosciences, Inc. today announced that Arthur A. Levin , Ph.D. has been appointed to the board.

Global biotechnology leader CSL (ASX: CSL) today announced the publication in the New England Journal of Medicine (NEJM) (Vol. 388 No. 8) results from the pivotal HOPE-B clinical study evaluating the efficacy, durability and safety of HEMGENIX® (etranacogene dezaparvovec-drlb).

ATCC and USP to provide solutions and standards to help customers deliver safe and high-quality biologics to patients more rapidly MANASSAS, Va.--( BUSINESS WIRE )-- ATCC , the world’s premier biological materials management and standards organization and U.S. Pharmacopeia ( USP ), an independent, international and scientific nonprofit organization, today announced a long-term, multi-year strategic collaboration to jointly provide co-branded reference materials and reference standards

IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson’s disease, announced that the company’s Year-end report for the period January-December 2022, has been published.

Photocure ASA reported Hexvix®/Cysview® revenues of NOK 94.9 million in the fourth quarter of 2022, and an EBITDA of minus NOK 16.9 million.

Redx Pharma and Jounce Therapeutics, Inc. announce an unanimously recommended Business Combination of the two companies via a proposed all share merger transaction.

In Q4, Immunovia continued to execute on its unique position as a leader in innovative early detection of pancreatic cancer.